-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $14

Benzinga·11/09/2026 20:19:59
Listen to the news
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $15 to $14.